This content is machine translated Biologics therapy for psoriasis Better outcomes through innovative methods of therapy management Personalized medicine is also becoming increasingly important in the field of inflammatory skin diseases. Currently, IL-17 and IL-23 inhibitors are most effective in moderate to severe psoriasis, but the response...…
View Post 15 min This content is machine translated Hidradenitis suppurativa Etiopathogenesis, diagnosis and treatment – an update The pathogenesis of hidradenitis suppurativa (HS) has not yet been fully clarified; it is assumed that there are multifactorial interactions. The most important risk factors and comorbidities include smoking, obesity...… CME-Test
View Post 8 min This content is machine translated Psoriasis vulgaris Practice-oriented recommendations for system therapy Fortunately, developments in recent years have led to the effective treatment of many patients with moderate to severe psoriasis. In addition to classical immunosuppressants, several biologics and a small molecule...…
View Post 3 min This content is machine translated Plaque psoriasis Current 5-year data on secukinumab A long-term extension analysis of the ERASURE and FIXTURE studies recently published in the British Journal of Dermatology demonstrates the long-lasting efficacy and safety of secukinumab in patients with moderate-to-severe...…
View Post 4 min This content is machine translated Biologics for psoriasis “Drug Survival” under the microscope The era of biologics has revolutionized the treatment options for patients with moderate to severe psoriasis in recent decades. Drug survival is an indicator of the longer-term efficacy and safety...…
View Post 8 min This content is machine translated Plaque psoriasis Updated guideline recommendations for children and adolescents Early treatment in children and adolescents with psoriasis is an important supply target. The updated s2k guideline provides evidence-based decision support for the selection of appropriate therapy. In the new edition...…
View Post 4 min This content is machine translated Psoriasis and psoriatic arthritis Secukinumab as a treatment option in pediatric patients – an update. Children and adolescents affected by psoriasis and/or psoriatic arthritis often suffer a great deal. Particularly in cases of severe symptoms, the quality of life of those affected and their families...…
View Post 6 min This content is machine translated Psoriasis in childhood and adolescence Secukinumab in juvenile plaque psoriasis – sustained efficacy demonstrated Treatment options for psoriasis patients in childhood and adolescence are much more limited compared to the treatment spectrum for adults. But pediatric patients can also benefit from targeted treatment. This...…
View Post 9 min This content is machine translated Plaque psoriasis Current therapeutic aspects An update on therapies currently available for plaque psoriasis. The introduction of biologics has changed the way patients with moderate to severe psoriasis are treated – with far-reaching implications for...…
View Post 5 min This content is machine translated National Psoriasis Day 2016 Current systemic treatments and Swiss guidelines The revolution in systemic psoriasis therapy began with the introduction of anti-TNF treatment after the turn of the millennium. Since then, the chain of further new psoriasis drug launches has...…